Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Deep vein thrombosis and pulmonary embolism secondary to urinary retention: a case report.

Kawada T, Yoshioka T, Araki M, Nose H, Oeda T.

J Med Case Rep. 2018 Mar 23;12(1):78. doi: 10.1186/s13256-018-1605-3.

2.

Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson's disease.

Murata M, Mihara M, Hasegawa K, Jeon B, Tsai CH, Nishikawa N, Oeda T, Yokoyama M, Robieson WZ, Chatamra K, Facheris MF, Benesh J.

Ther Adv Neurol Disord. 2018 Feb 26;11:1756286418759315. doi: 10.1177/1756286418759315. eCollection 2018.

3.

[A case of subarachnoid hemorrhage due to infective endocarditis by methicillin-resistant coagulase-negative staphylococcus].

Kajikawa S, Oeda T, Park K, Yamamoto K, Sugiyama H, Sawada H.

Rinsho Shinkeigaku. 2017 Dec 27;57(12):775-777. doi: 10.5692/clinicalneurol.cn-001053. Epub 2017 Nov 28. Japanese.

PMID:
29187685
4.

Oxybuprocaine for apraxia of lid opening in Parkinson's disease: A placebo-controlled pilot trial.

Kohsaka M, Oeda T, Umemura A, Tomita S, Park K, Yamamoto K, Sugiyama H, Sawada H.

Mov Disord. 2018 Mar;33(3):494-495. doi: 10.1002/mds.27243. Epub 2017 Nov 23. No abstract available.

PMID:
29168901
5.

Efficacy and safety of levodopa-carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson's disease patients.

Murata M, Mihara M, Hasegawa K, Jeon B, Tsai CH, Nishikawa N, Oeda T, Yokoyama M, Robieson WZ, Ryman D, Eaton S, Chatamra K, Benesh J.

NPJ Parkinsons Dis. 2016 Nov 3;2:16020. doi: 10.1038/npjparkd.2016.20. eCollection 2016.

6.

Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.

Tanaka K, Miyake Y, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Nakamura Y; Fukuoka Kinki Parkinson’s Disease Study Group.

Neurosci Lett. 2017 Mar 16;643:97-102. doi: 10.1016/j.neulet.2017.02.037. Epub 2017 Feb 16.

PMID:
28216333
7.

Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders.

Ishikawa T, Imamura K, Kondo T, Koshiba Y, Hara S, Ichinose H, Furujo M, Kinoshita M, Oeda T, Takahashi J, Takahashi R, Inoue H.

Hum Mol Genet. 2016 Dec 1;25(23):5188-5197. doi: 10.1093/hmg/ddw339.

8.

Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.

Sadahira T, Wada K, Araki M, Ishii A, Takamoto A, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y, Kumon H; Okayama Urological Research Group (OURG).

J Antimicrob Chemother. 2017 Feb;72(2):529-534. doi: 10.1093/jac/dkw424. Epub 2016 Oct 12.

PMID:
27733519
9.

PARK16 polymorphisms, interaction with smoking, and sporadic Parkinson's disease in Japan.

Miyake Y, Tanaka K, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Nakamura Y; Fukuoka Kinki Parkinson's Disease Study Group.

J Neurol Sci. 2016 Mar 15;362:47-52. doi: 10.1016/j.jns.2016.01.021. Epub 2016 Jan 14.

PMID:
26944116
10.

A case of alcoholic pellagra encephalopathy presenting with spinal myoclonus.

Park K, Oeda T, Sawada H.

Neurol Clin Pract. 2015 Dec;5(6):472-474. doi: 10.1212/CPJ.0000000000000165. No abstract available.

11.

Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease.

Oeda T, Umemura A, Mori Y, Tomita S, Kohsaka M, Park K, Inoue K, Fujimura H, Hasegawa H, Sugiyama H, Sawada H.

Neurobiol Aging. 2015 Dec;36(12):3306-3313. doi: 10.1016/j.neurobiolaging.2015.08.027. Epub 2015 Sep 7.

12.

Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease.

Umemura A, Oeda T, Yamamoto K, Tomita S, Kohsaka M, Park K, Sugiyama H, Sawada H.

PLoS One. 2015 Aug 26;10(8):e0136722. doi: 10.1371/journal.pone.0136722. eCollection 2015.

13.

Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study.

Tomita S, Oeda T, Umemura A, Kohsaka M, Park K, Yamamoto K, Sugiyama H, Mori C, Inoue K, Fujimura H, Sawada H.

PLoS One. 2015 Aug 13;10(8):e0135823. doi: 10.1371/journal.pone.0135823. eCollection 2015.

14.

Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease.

Sawada H, Oeda T, Umemura A, Tomita S, Kohsaka M, Park K, Yamamoto K, Sugiyama H.

PLoS One. 2015 Jul 28;10(7):e0134118. doi: 10.1371/journal.pone.0134118. eCollection 2015.

15.

[A case of refractory generalized myasthenia gravis with anti-acetylcholine receptor antibodies treated with rituximab].

Hayashi R, Tahara M, Oeda T, Konishi T, Sawada H.

Rinsho Shinkeigaku. 2015;55(4):227-32. doi: 10.5692/clinicalneurol.55.227. Japanese.

PMID:
25904250
16.

Delirium and high fever are associated with subacute motor deterioration in Parkinson disease: a nested case-control study.

Umemura A, Oeda T, Tomita S, Hayashi R, Kohsaka M, Park K, Sugiyama H, Sawada H.

PLoS One. 2014 Jun 2;9(6):e94944. doi: 10.1371/journal.pone.0094944. eCollection 2014.

17.

Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study.

Sawada H, Oeda T, Umemura A, Tomita S, Hayashi R, Kohsaka M, Yamamoto K, Sudoh S, Sugiyama H.

PLoS One. 2014 Jan 31;9(1):e85886. doi: 10.1371/journal.pone.0085886. eCollection 2014.

18.

Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study.

Sawada H, Oeda T, Yamamoto K, Umemura A, Tomita S, Hayashi R, Kohsaka M, Kawamura T.

BMC Neurol. 2013 Oct 12;13:145. doi: 10.1186/1471-2377-13-145.

20.

Clinical factors associated with abnormal postures in Parkinson's disease.

Oeda T, Umemura A, Tomita S, Hayashi R, Kohsaka M, Sawada H.

PLoS One. 2013 Sep 19;8(9):e73547. doi: 10.1371/journal.pone.0073547. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/d5228e50-2098-44c9-b663-829dd9b4b97e.

Supplemental Content

Loading ...
Support Center